Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Tabletop Fire Pit Lawsuit Individuals who suffered severe burns, or families who lost a loved one in a tabletop fire pit explosion, may be eligible for financial compensation through a fire pit injury lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Dupixent Lawsuit Dupixent lawsuits are being investigated for patients who developed rare blood cancers such as cutaneous T-cell lymphoma (CTCL) after receiving injections, alleging that Sanofi and Regeneron failed to warn about the potential risks of immune suppression and delayed cancer diagnosis.
Ocaliva Lawsuit Ocaliva lawsuits are being investigated for users who experienced liver failure, cirrhosis progression, transplant, or death after taking the drug, alleging that Intercept Pharmaceuticals failed to warn about the risk of dosing toxicity and accelerated liver damage.
Roblox Lawsuit Families are filing Roblox lawsuits after children were targeted by predators for grooming, sextortion, sexual abuse, or exploitation on the platform. Learn who qualifies, what cases allege, and how to file a confidential claim.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Paraquat Statute of Limitations, Other Defenses Raised in Motion to Dismiss Filed By Chevron September 16, 2021 Irvin Jackson Add Your Comments Chevron, U.S.A. has filed a motion to dismiss claims raised in a large number of Paraquat lawsuits, arguing that claims the company is responsible for Parkinson’s disease diagnosed after exposure to the weedkiller should be barred by some states’ statutes of limitations, and other defenses that should preclude individual plaintiffs from obtaining a settlement or recovery. There are currently about 290 product liability lawsuits filed throughout the federal court system against Chevron and Syngenta, who manufactured and sold Paraquat-based herbicides at various times over the past six decades. Each of the complaints raise similar allegations that farmers and others in the agricultural industry were not adequately warned about the link between Paraquat and Parkinson’s disease, and the size of the litigation is expected to continue to grow over the next year, as more individuals contact lawyers and file claims. Given common questions of fact and law raised in the lawsuits, the federal Paraquat Parkinson’s litigation is centralized before U.S. District Judge Nancy J. Rosenstengel in the Southern District of Illinois, as part of a multidistrict litigation (MDL) for coordinated discovery and pretrial proceedings. PARAQUAT Parkinson’s Lawsuits Were you or a loved one exposed to Paraquat? Lawyers are reviewing Paraquat lawsuits for individuals who were exposed to Paraquat and developed Parkinson’s disease. Learn More SEE IF YOU QUALIFY FOR COMPENSATION PARAQUAT Parkinson’s Lawsuits Were you or a loved one exposed to Paraquat? Lawyers are reviewing Paraquat lawsuits for individuals who were exposed to Paraquat and developed Parkinson’s disease. Learn More SEE IF YOU QUALIFY FOR COMPENSATION On September 13, Chevron U.S.A. filed a motion to dismiss (PDF) claims alleging use of Paraquat after the company stopped distributing the product, public nuisance claims raised in certain complaints, and lawsuits the company argues should be bared by statutes of repose or statutes of limitations. Chevron indicates it stopped selling and distributing Paraquat in 1986, yet points out that the company has been named as a defendant even in claims where plaintiffs indicate that they started using the product after 1990, when Chevron argues it is “implausible” that exposures were caused by Paraquat products sold by Chevron. According to a memorandum (PDF) in support of the motion to dismiss, Chevron argues that the Paraquat statute of limitations and statute of repose should prevent claims filed in Illinois, Indiana, Iowa, Georgia, North Carolina and Connecticut, which all have laws that limit the time in which one can file a lawsuit following the sale of a product, regardless of when injury happened or when plaintiffs learned of a connection between their injuries and Paraquat use. In addition, Chevron also claim many of the lawsuits are time barred in Alabama, Maine, Michigan, Mississippi, Nebraska and New York, claiming these states bar the filing of lawsuits based on the amount of time following an injury, regardless of when plaintiffs discovered a connection between the use of Paraquat and Parkinson’s disease. The motion also seeks to dismiss any public nuisance claims, arguing that the sale of lawful products are not recognized as public nuisance by the Courts, and to dismiss warranty claims in Alabama, Arizona, Connecticut, Illinois, Indiana, Kentucky, Louisiana, Maryland, Minnesota, Mississippi, Missouri, Nebraska, New York, North Dakota, Oklahoma, Pennsylvania, Tennessee, Texas, Virginia, Washington, and Wisconsin; stating that those states limit warranty claims based on the time of sale. Plaintiffs have yet to file a response to the motion, and Judge Rosenstengel has not indicated when the Court may consider or rule on the motion. However, if successful, it may result in Chevron being dismissed as a defendant from most, if not all, Paraquat lawsuits filed by former users diagnosed with Parkinson’s disease. As part of the coordinated pretrial proceedings in the growing litigation brought against both Chevron and Syngenta, Judge Rosenstengel has previously indicated that a series of early Paraquat trial dates expected to begin by November 2022, which are designed to help the parties gauge how juries are likely to respond to certain evidence and testimony that will be repeated throughout the claims. Evidence of Parkinson’s Disease Risk from Paraquat Paraquat has been widely used on farms and within the agricultural industry for decades, to control weeds and long grass. It is sold exclusively through farming and agricultural supply stores under a number of brand names, including Gramoxone, Blanco, Cyclone, Bonedry and others. Since it is known to be toxic and users face a risk of Paraquat poisoning if even a small amount of the herbicide is ingested, the herbicide is only available in the United States under a program that requires users to go through a training program on the safe handling of the herbicide. However, plaintiffs allege the manufacturers failed to warn about the risk that Paraquat may cause Parkinson’s disease and other neurological injuries, even when the recommended precautions are taken. In 2012, researchers from UCLA found a link between pesticide use and a risk of developing Parkinson’s, indicating that individuals who suffered a traumatic brain injury (TBI) and were exposed to Paraquat were three times more likely to develop Parkinson’s disease. Another study published in May 2013 found yet another link between pesticide exposure and an increased risk of developing Parkinson’s disease, indicating that pesticide exposure may increase the risk of developing Parkinson’s by 60 percent. That study also found the risk increased with exposure to any type of pesticide, herbicide or solvent; but exposure to specific chemicals doubled the risk. Chemicals used in the test included Paraquat, Maneb and other pesticides. In March 2016, the EPA announced it would be re-evaluating the health risks with Paraquat, and a number of health experts and consumer advocacy groups have called on the agency to remove Paraquat-based herbicides from the market in the U.S. However, it continues to be used by farmers and other industries for weed and grass control, potentially exposing individuals handling, mixing or applying the Paraquat to life-long health risks. Parkinson’s disease affects more than 500,000 Americans, with approximately 50,000 new cases each year. The disease causes the loss of motor functions, causing imbalance and shaking, which gets progressively worse over time. Written by: Irvin Jackson Senior Legal Journalist & Contributing Editor Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends. Tags: Chevron, Herbicide, Paraquat, Parkinsons Disease, Weed Killer More Paraquat Lawsuit Stories Paraquat Parkinson’s Disease Settlement Payout Amounts Still Being Finalized October 3, 2025 Paraquat MDL Lawsuit Deadlines Extended Again, as Settlement Details Finalized August 12, 2025 Paraquat Parkinson’s Disease Settlement Terms Still Being Finalized June 30, 2025 0 Comments CompanyThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA Term Δ MORE TOP STORIES Ocaliva Lawsuits Over Failure To Warn About Liver Injury Problems May Follow Market Withdrawal (Posted: yesterday) Ocaliva, promoted as a treatment to prevent liver injury, has been recalled following reports of high rates of liver damage and patient deaths. MORE ABOUT: OCALIVA LAWSUITOcaliva Market Withdrawal To Take Final Effect on Nov. 14 (10/21/2025)Ocaliva Liver Side Effects Are Higher for Patients Who Didn’t Respond to Drug: Study (10/14/2025)Ocaliva Recall Issued Due to Liver Injury Risks (09/12/2025) Internal Bra Mesh Failure Stories Highlight Risk of Pain, Infections and Other Problems (Posted: 2 days ago) Women are sharing alarming reports of pain, infections, and reconstruction failures caused by internal bra mesh implants like GalaFLEX, as the FDA confirms these devices were never approved for breast surgery and lawsuits now allege manufacturers failed to warn about the risks. MORE ABOUT: BREAST MESH LAWSUITInternal Bra Side Effects Raise Questions About Manufacturers’ Knowledge of Mesh Failures (10/27/2025)Breast Mesh Problems Prompted FDA Warnings Over Off-Label Use (10/15/2025)Breast Mesh Lawsuits May Follow Recent Studies Highlighting Internal Bra Complications (10/09/2025) Update on Hair Relaxer Lawsuit Status To Be Provided to Court at MDL Hearing (Posted: 3 days ago) A federal judge will hold a hearing on Thursday with hair relaxer lawsuit parties in order to update the court on the status of the ongoing litigation. MORE ABOUT: HAIR RELAXER LAWSUITHair Relaxer Injury Lawsuit Against L’Oreal, Strength of Nature Cleared To Move Forward (10/20/2025)MDL Judge To Weigh Hair Relaxer Cancer Evidence in Mid-2026 (09/11/2025)Uterine Cancer Cases Expected to ‘Increase Substantially’ Over Next 30 Years: Study (07/08/2025)
Ocaliva Lawsuits Over Failure To Warn About Liver Injury Problems May Follow Market Withdrawal (Posted: yesterday) Ocaliva, promoted as a treatment to prevent liver injury, has been recalled following reports of high rates of liver damage and patient deaths. MORE ABOUT: OCALIVA LAWSUITOcaliva Market Withdrawal To Take Final Effect on Nov. 14 (10/21/2025)Ocaliva Liver Side Effects Are Higher for Patients Who Didn’t Respond to Drug: Study (10/14/2025)Ocaliva Recall Issued Due to Liver Injury Risks (09/12/2025)
Internal Bra Mesh Failure Stories Highlight Risk of Pain, Infections and Other Problems (Posted: 2 days ago) Women are sharing alarming reports of pain, infections, and reconstruction failures caused by internal bra mesh implants like GalaFLEX, as the FDA confirms these devices were never approved for breast surgery and lawsuits now allege manufacturers failed to warn about the risks. MORE ABOUT: BREAST MESH LAWSUITInternal Bra Side Effects Raise Questions About Manufacturers’ Knowledge of Mesh Failures (10/27/2025)Breast Mesh Problems Prompted FDA Warnings Over Off-Label Use (10/15/2025)Breast Mesh Lawsuits May Follow Recent Studies Highlighting Internal Bra Complications (10/09/2025)
Update on Hair Relaxer Lawsuit Status To Be Provided to Court at MDL Hearing (Posted: 3 days ago) A federal judge will hold a hearing on Thursday with hair relaxer lawsuit parties in order to update the court on the status of the ongoing litigation. MORE ABOUT: HAIR RELAXER LAWSUITHair Relaxer Injury Lawsuit Against L’Oreal, Strength of Nature Cleared To Move Forward (10/20/2025)MDL Judge To Weigh Hair Relaxer Cancer Evidence in Mid-2026 (09/11/2025)Uterine Cancer Cases Expected to ‘Increase Substantially’ Over Next 30 Years: Study (07/08/2025)